Reprint
Pathogenesis and Therapy of Oral Carcinogenesis
Edited by
August 2023
224 pages
- ISBN978-3-0365-8431-7 (Hardback)
- ISBN978-3-0365-8430-0 (PDF)
This book is a reprint of the Special Issue Pathogenesis and Therapy of Oral Carcinogenesis that was published in
Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary
We present our reprint dedicated to the study of oral squamous cell carcinoma (OSCC). Despite advances in diagnosis and treatment, OSCC remains a challenge for scientists and clinicians worldwide. This compilation of articles addresses novel biomarkers and therapeutic targets for the prevention and treatment of OSCC. Articles cover topics such as the combined use of pathway inhibitors in cancer control, the role of genes and microRNAs, the interaction between smoking and HPV infection, and potential biomarkers for diagnosis and therapy. These publications provide insights into the latest research and inspire further innovation.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
oropharyngeal squamous cell carcinoma; HPV; nucleophosmin; inflammation; mast cells; MCs; oral squamous cell carcinoma; OSCC; soluble factors; CC chemokine ligand 2; CCL2; MCP-1; oral squamous cell carcinoma; lymph node metastases; molecular imaging; immunohistochemistry; urokinase-type plasminogen activator receptor; tissue factor; integrin αvβ6; squamous cell carcinoma; oral cavity; biomarkers; nEGFR; immunocytochemistry; caveolin-1; cell polarization; cholesterol; migration; oral squamous cell carcinoma; oral squamous cell carcinoma; OSCC; E2F2; miR-125b-5p; miR-155-3p; miR-214-5p; tumour; margin; cancer; head and neck; human papillomavirus; cigarette smoke; SOD2; DNA damage; PEITC; Nutri-Jelly; oral cancer; tertiary chemoprevention; p53; clinical trial; survival; quality of life; oral cancer; polymorphism; lysyl oxidase; human; mouse model; 4 NQO; extracellular matrix; tumor suppressor; pathogenesis; periodontitis; circulating cell-free DNA; oral disease; periodontics; tooth loss: oral cancer; trials; Wnt pathway; hedgehog pathway; β-catenin; PRI-724; vismodegib; erlotinib; HS-173; head and neck cancer; cancer stem cells; synergism; epidermal growth factor receptor; EGFR; oral cancer; prognosis; systematic review; meta-analysis